Comparison of LTA in Patients with Bleeding Disorder of Unknown Cause and Healthy Blood Donors – Now on RPTH Journal
RPTH Journal shared a post on LinkedIn:
“A new study reassesses guideline-recommended agonist concentrations for light transmission aggregometry (LTA). By comparing individuals with bleeding disorder of unknown cause to healthy donors, the work from Lena-Theresa Fanenbruck highlights important considerations for interpreting LTA results in clinical practice.
Read the full article in RPTH for the full analysis and implications for testing standards.”
Ttile: Comparison of light transmission aggregometry in patients with bleeding disorder of unknown cause and healthy blood donors
Authors: Lena-Theresa Fanenbruck, Michael Metze, Maria Weise, Martin Federbusch, Roland Siegemund, Martin Reinhard Henschler, Annelie Siegemund, Sirak Petros, Christian Pfrepper
Get the latest insights on Hemostasis Today.
-
Apr 6, 2026, 16:39Dhinesh Selvaraju: FDA Approves Narsoplimab (Yartemlea) as 1st Treatment for TA-TMA in Adults and Children
-
Apr 6, 2026, 16:38Linda Vorberg: A Detailed Analysis on The Usefulness of CT for DL-Based Stroke Lesion Segmentation
-
Apr 6, 2026, 16:37Colleen Hearn: Telestroke Helps Resource-Limited Facilities Gain Access to Unavailable Expertise
-
Apr 6, 2026, 16:37Nicolas Hubacz: AI Maps Neuroplasticity in Stroke Recovery – How the Brain Adapts After Injury
-
Apr 6, 2026, 16:36Cristina de Diego Alonso: Movement Is Not Just an Exercise, It Is The Rhythm of Daily Life
-
Apr 6, 2026, 16:35Charles Okyere Boadu: What Is The Most Likely Cause of Persistent Thrombocytopenia Despite Transfusion?
-
Apr 6, 2026, 16:34Tumor Mutations and VTE Risk – New Insights from a 12,500-Patient Cancer Study – JTH
-
Apr 6, 2026, 16:31Wolfgang Miesbach: New Real-World Data Reveal Ongoing Burden in Moderate-to-Severe Haemophilia A
-
Apr 6, 2026, 16:26Heghine Khachatryan։ Targeting High Risk Antiphospholipid Syndrome in Pregnancy with Hydroxychloroquine